Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

31.06  -0.83 (-2.6%)

After market: 29.9554 -1.1 (-3.56%)

Fundamental Rating

5

Taking everything into account, CNK scores 5 out of 10 in our fundamental rating. CNK was compared to 72 industry peers in the Entertainment industry. CNK has an excellent profitability rating, but there are concerns on its financial health. CNK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
CNK had a positive operating cash flow in the past year.
In multiple years CNK reported negative net income over the last 5 years.
CNK had a positive operating cash flow in 4 of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a Return On Assets of 5.16%. This is amongst the best in the industry. CNK outperforms 83.33% of its industry peers.
Looking at the Return On Equity, with a value of 69.13%, CNK belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
The Return On Invested Capital of CNK (7.83%) is better than 80.56% of its industry peers.
CNK had an Average Return On Invested Capital over the past 3 years of 5.91%. This is significantly below the industry average of 22.90%.
The last Return On Invested Capital (7.83%) for CNK is above the 3 year average (5.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROIC 7.83%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With an excellent Profit Margin value of 8.02%, CNK belongs to the best of the industry, outperforming 84.72% of the companies in the same industry.
In the last couple of years the Profit Margin of CNK has grown nicely.
Looking at the Operating Margin, with a value of 10.66%, CNK belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
In the last couple of years the Operating Margin of CNK has remained more or less at the same level.
CNK has a better Gross Margin (64.38%) than 73.61% of its industry peers.
In the last couple of years the Gross Margin of CNK has remained more or less at the same level.
Industry RankSector Rank
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNK is creating some value.
The number of shares outstanding for CNK has been increased compared to 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
The debt/assets ratio for CNK has been reduced compared to a year ago.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that CNK is in the distress zone and has some risk of bankruptcy.
CNK's Altman-Z score of 1.25 is in line compared to the rest of the industry. CNK outperforms 50.00% of its industry peers.
CNK has a debt to FCF ratio of 11.16. This is a negative value and a sign of low solvency as CNK would need 11.16 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.16, CNK perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
CNK has a Debt/Equity ratio of 5.66. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CNK (5.66) is worse than 76.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Altman-Z 1.25
ROIC/WACC1.02
WACC7.66%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNK may have some problems paying its short term obligations.
CNK has a Current ratio (0.79) which is in line with its industry peers.
A Quick Ratio of 0.76 indicates that CNK may have some problems paying its short term obligations.
CNK has a Quick ratio of 0.76. This is comparable to the rest of the industry: CNK outperforms 41.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CNK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.83%.
The Earnings Per Share has been growing slightly by 4.49% on average over the past years.
The Revenue has decreased by -0.80% in the past year.
CNK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.47% yearly.
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%

3.2 Future

The Earnings Per Share is expected to grow by 9.85% on average over the next years. This is quite good.
CNK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.68% yearly.
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

CNK is valuated rather expensively with a Price/Earnings ratio of 20.43.
Based on the Price/Earnings ratio, CNK is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.65.
Based on the Price/Forward Earnings ratio of 13.25, the valuation of CNK can be described as correct.
87.50% of the companies in the same industry are more expensive than CNK, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CNK to the average of the S&P500 Index (21.27), we can say CNK is valued slightly cheaper.
Industry RankSector Rank
PE 20.43
Fwd PE 13.25
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

77.78% of the companies in the same industry are more expensive than CNK, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 81.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.22
EV/EBITDA 10.46
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of CNK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.55
EPS Next 2Y7.46%
EPS Next 3Y9.85%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.50%, CNK is not a good candidate for dividend investing.
CNK's Dividend Yield is rather good when compared to the industry average which is at 6.52. CNK pays more dividend than 80.56% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CNK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

CNK has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y7.46%
EPS Next 3Y9.85%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (6/23/2025, 8:04:00 PM)

After market: 29.9554 -1.1 (-3.56%)

31.06

-0.83 (-2.6%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners122.04%
Inst Owner Change-2.85%
Ins Owners2.11%
Ins Owner Change-5.79%
Market Cap3.57B
Analysts75
Price Target33.94 (9.27%)
Short Float %23.99%
Short Ratio6.54
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2025-05-29 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.93%
Min EPS beat(2)-100.53%
Max EPS beat(2)-13.33%
EPS beat(4)2
Avg EPS beat(4)62.52%
Min EPS beat(4)-100.53%
Max EPS beat(4)254.24%
EPS beat(8)5
Avg EPS beat(8)64.97%
EPS beat(12)6
Avg EPS beat(12)-8.2%
EPS beat(16)7
Avg EPS beat(16)1.09%
Revenue beat(2)1
Avg Revenue beat(2)0.74%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)10
Avg Revenue beat(12)2.73%
Revenue beat(16)13
Avg Revenue beat(16)6.14%
PT rev (1m)1.44%
PT rev (3m)2.2%
EPS NQ rev (1m)3.65%
EPS NQ rev (3m)15.73%
EPS NY rev (1m)4.99%
EPS NY rev (3m)-13.42%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)5.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 20.43
Fwd PE 13.25
P/S 1.19
P/FCF 16.22
P/OCF 9.67
P/B 10.23
P/tB N/A
EV/EBITDA 10.46
EPS(TTM)1.52
EY4.89%
EPS(NY)2.34
Fwd EY7.55%
FCF(TTM)1.91
FCFY6.16%
OCF(TTM)3.21
OCFY10.35%
SpS26.18
BVpS3.04
TBVpS-10.38
PEG (NY)N/A
PEG (5Y)4.55
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROCE 9.05%
ROIC 7.83%
ROICexc 9.75%
ROICexgc 21.27%
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
FCFM 7.31%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Debt/EBITDA 3.81
Cap/Depr 75.61%
Cap/Sales 4.96%
Interest Coverage 2.19
Cash Conversion 71.26%
Profit Quality 91.22%
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 1.25
F-Score6
WACC7.66%
ROIC/WACC1.02
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A
EBIT growth 1Y-10.88%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year81.21%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y52.49%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y40.69%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%